Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Epoprostenol Therapy for a Pediatric Patient With Subacute Heparin-Induced Thrombocytopenia and a Ventricular Assist Device Undergoing Heart Transplant: A Case Report

Epoprostenol Therapy for a Pediatric Patient With Subacute Heparin-Induced Thrombocytopenia and a... Concerns remain regarding the use of direct thrombin inhibitors for cardiopulmonary bypass anticoagulation in pediatric patients with heparin-induced thrombocytopenia undergoing complex cardiac surgery. We describe the safe and effective use of epoprostenol sodium as an alternative therapy before heparin exposure for a pediatric patient with subacute heparin-induced thrombocytopenia and a ventricular assist device undergoing heart transplant. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png A & A Practice Wolters Kluwer Health

Epoprostenol Therapy for a Pediatric Patient With Subacute Heparin-Induced Thrombocytopenia and a Ventricular Assist Device Undergoing Heart Transplant: A Case Report

Download PDF
3 pages

Loading next page...
 
/lp/wolters-kluwer-health/epoprostenol-therapy-for-a-pediatric-patient-with-subacute-heparin-SLNyBCgnCH
Publisher
Wolters Kluwer Health
Copyright
Copyright © 2018 International Anesthesia Research Society
ISSN
2575-3126
eISSN
2575-3126
DOI
10.1213/XAA.0000000000000818
Publisher site
See Article on Publisher Site

Abstract

Concerns remain regarding the use of direct thrombin inhibitors for cardiopulmonary bypass anticoagulation in pediatric patients with heparin-induced thrombocytopenia undergoing complex cardiac surgery. We describe the safe and effective use of epoprostenol sodium as an alternative therapy before heparin exposure for a pediatric patient with subacute heparin-induced thrombocytopenia and a ventricular assist device undergoing heart transplant.

Journal

A & A Practice – Wolters Kluwer Health

Published: Dec 15, 2018

References

  • Pathophysiology of heparin-induced thrombocytopenia. Clinical and diagnostic implications—a review.
    Fabris, F; Ahmad, S; Cella, G; Jeske, WP; Walenga, JM; Fareed, J
  • Heparin induced thrombocytopenia (HIT) in pediatric cardiac surgery: an emerging cause of morbidity and mortality.
    Alsoufi, B; Boshkow, LK; Kirby, A
  • Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence- Based Clinical Practice Guidelines.
    Linkins, LA; Dans, AL; Moores, LK
  • Comparison of bivalirudin and argatroban for the management of heparin-induced thrombocytopenia.
    Skrupky, LP; Smith, JR; Deal, EN
  • Challenging argatroban management of a child on extracorporeal support and subsequent heart transplant.
    Latham, GJ; Jefferis Kirk, C; Falconer, A; Dickey, R; Albers, EL; McMullan, DM
  • Modulation of human platelet adenylate cyclase by prostacyclin (PGX).
    Gorman, RR; Bunting, S; Miller, OV
  • Stability of prostacyclin in human and rabbit whole blood and plasma
    Lucas, FV; Skrinska, VA; Chisolm, GM; Hesse, BL
  • Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia.
    Aouifi, A; Blanc, P; Piriou, V
  • Heparin-induced thrombocytopenia type II in an infant with a congenital heart defect–anticoagulation during cardiopulmonary bypass with epoprostenol sodium and heparin.
    von Heymann, C; Hagemeyer, E; Kastrup, M
  • Perioperative care in an adolescent patient with heparin-induced thrombocytopenia for placement of a cardiac assist device and heart transplantation: case report and literature review.
    Kamata, M; Sebastian, R; McConnell, PI; Gomez, D; Naguib, A; Tobias, JD
  • Clinical and laboratory diagnosis of heparin-induced thrombocytopenia: an integrated approach.
    Cuker, A
  • Challenging diagnosis and treatment of HIT in child with ventricular assistance device.
    Weintraub, L; Driscoll, C; Aydin, S; Lamour, JM; Weinstein, S; Manwani, D
  • Impact of heparin-induced thrombocytopenia on outcome in patients with ventricular assist device support: single-institution experience in 358 consecutive patients.
    Koster, A; Huebler, S; Potapov, E
  • Prostacyclin administration during cardiopulmonary bypass in man.
    Longmore, DB; Bennett, JG; Hoyle, PM
  • Intraoperative infusion of epoprostenol sodium for patients with heparin-induced thrombocytopenia undergoing cardiac surgery.
    Yamamoto, K; Sakata, R; Iguro, Y; Ueno, T; Ueno, M; Ueno, T